Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer.
Chang J, Lucas MC, Leonte LE, Garcia-Montolio M, Singh LB, Findlay AD, Deodhar M, Foot JS, Jarolimek W, Timpson P, Erler JT, Cox TR.
Chang J, et al.
Oncotarget. 2017 Apr 18;8(16):26066-26078. doi: 10.18632/oncotarget.15257.
Oncotarget. 2017.
PMID: 28199967
Free PMC article.